Dyslipidemia Terminated Phase 2 Trials for Rosuvastatin (DB01098)

Also known as: Dyslipaemia / Dyslipidaemia / Dyslipidemias / Dyslipidaemias

IndicationStatusPhase
DBCOND0020718 (Dyslipidemia)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01863225Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in DyslipidemiaBasic Science